DK3723791T3 - Rekombinante igg-fc-multimere til behandling af neuromyelitis optica - Google Patents
Rekombinante igg-fc-multimere til behandling af neuromyelitis optica Download PDFInfo
- Publication number
- DK3723791T3 DK3723791T3 DK18829780.8T DK18829780T DK3723791T3 DK 3723791 T3 DK3723791 T3 DK 3723791T3 DK 18829780 T DK18829780 T DK 18829780T DK 3723791 T3 DK3723791 T3 DK 3723791T3
- Authority
- DK
- Denmark
- Prior art keywords
- multimers
- treatment
- neuromyelitis optica
- recombinant igg
- igg
- Prior art date
Links
- 208000008795 neuromyelitis optica Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/35—Valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/53—Hinge
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762598592P | 2017-12-14 | 2017-12-14 | |
| EP18168448 | 2018-04-20 | ||
| PCT/EP2018/084894 WO2019115745A1 (en) | 2017-12-14 | 2018-12-14 | RECOMBINANT igG Fc MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3723791T3 true DK3723791T3 (da) | 2024-04-08 |
Family
ID=64949238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18829780.8T DK3723791T3 (da) | 2017-12-14 | 2018-12-14 | Rekombinante igg-fc-multimere til behandling af neuromyelitis optica |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210095006A1 (da) |
| EP (1) | EP3723791B1 (da) |
| JP (1) | JP7351835B2 (da) |
| CN (1) | CN112004550A (da) |
| AU (1) | AU2018382586A1 (da) |
| CA (1) | CA3085385A1 (da) |
| DK (1) | DK3723791T3 (da) |
| WO (1) | WO2019115745A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10373019B2 (en) * | 2016-01-13 | 2019-08-06 | Ford Global Technologies, Llc | Low- and high-fidelity classifiers applied to road-scene images |
| CN114401985A (zh) * | 2019-09-13 | 2022-04-26 | 康诺贝林伦瑙有限公司 | 用于治疗免疫复合物介导的肾病症的重组IgG Fc多聚体 |
| CN114894911B (zh) * | 2022-03-18 | 2023-10-24 | 辽宁成大生物股份有限公司 | 一种控制牛血清产品质量方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
| GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
| GB9720054D0 (en) | 1997-09-19 | 1997-11-19 | Celltech Therapeutics Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| PL1644412T5 (pl) | 2003-07-01 | 2019-01-31 | Ucb Biopharma Sprl | Modyfikowane fragmenty Fab przeciwciała |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| US8680237B2 (en) | 2007-06-01 | 2014-03-25 | Gliknik Inc. | Immunoglobulin constant region FC receptor binding agents |
| MX347343B (es) | 2010-07-28 | 2017-04-21 | Gliknik Inc | Proteinas de fusion de fragmentos de proteinas humanas naturales para crear composiciones de fc de inmunoglobulinas multimerizadas ordenadamente. |
| AU2012392760C1 (en) | 2012-10-17 | 2021-08-12 | CSL Behring Lengnau AG | Immunomodulatory proteins |
| EP3114137A1 (en) * | 2014-03-05 | 2017-01-11 | UCB Biopharma SPRL | Multimeric fc proteins |
| JP6851200B2 (ja) * | 2014-03-05 | 2021-03-31 | ユーシービー バイオファルマ エスアールエル | 多量体Ｆｃタンパク質 |
| US20180044416A1 (en) * | 2015-03-05 | 2018-02-15 | Ucb Biopharma Sprl | Polymeric Fc proteins and methods of screening to alter their functional characteristics |
| GB201511787D0 (en) * | 2015-07-06 | 2015-08-19 | Ucb Biopharma Sprl | Proteins |
| KR102649702B1 (ko) | 2015-07-24 | 2024-03-21 | 글리크닉 인코포레이티드 | 향상된 상보체 결합을 갖는 규칙적으로 다형체화된 면역글로불린 fc 조성물을 생성하기 위한 인간 단백질 단편의 융합 단백질 |
| BR112018014668A2 (pt) | 2016-01-27 | 2018-12-11 | Csl Behring Recombinant Facility Ag | multímeros de fc de igg recombinante |
| BR112018070022A2 (pt) | 2016-03-30 | 2019-02-05 | Ab biosciences inc | composições de imunoglobulina intravenosa recombinante (rivig) e métodos para sua produção e uso |
-
2018
- 2018-12-14 EP EP18829780.8A patent/EP3723791B1/en active Active
- 2018-12-14 JP JP2020531912A patent/JP7351835B2/ja active Active
- 2018-12-14 AU AU2018382586A patent/AU2018382586A1/en active Pending
- 2018-12-14 CA CA3085385A patent/CA3085385A1/en active Pending
- 2018-12-14 US US16/772,186 patent/US20210095006A1/en active Pending
- 2018-12-14 DK DK18829780.8T patent/DK3723791T3/da active
- 2018-12-14 CN CN201880080469.7A patent/CN112004550A/zh active Pending
- 2018-12-14 WO PCT/EP2018/084894 patent/WO2019115745A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN112004550A (zh) | 2020-11-27 |
| WO2019115745A1 (en) | 2019-06-20 |
| JP2021506772A (ja) | 2021-02-22 |
| US20210095006A1 (en) | 2021-04-01 |
| JP7351835B2 (ja) | 2023-09-27 |
| EP3723791A1 (en) | 2020-10-21 |
| AU2018382586A1 (en) | 2020-07-02 |
| EP3723791B1 (en) | 2024-02-21 |
| CA3085385A1 (en) | 2019-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3349758T3 (da) | Fremgangsmåder til behandling af arenaviridae-virusinfektioner | |
| DK3173092T3 (da) | Rna-holdig sammensætning til behandling af tumorsygdomme | |
| DK3245206T3 (da) | Pyrazinforbindelser til behandling af infektionssygdomme | |
| DK3399962T3 (da) | Oftalmisk sammensætning til behandling af tør øjensygdom | |
| DK3466432T3 (da) | Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner | |
| DK3288577T3 (da) | Adiponectin-peptidomimetika til behandling af øjenlidelser | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3436074T3 (da) | Thiazolidforbindelser til behandling af virale infektioner | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3261661T3 (da) | Menotropin til behandling af infertilitet | |
| DK3439661T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3618845T3 (da) | Peptider til behandling af diabetes | |
| DK3210973T3 (da) | Heteroarylforbindelser til behandling af oftalmiske sygdomme | |
| DK3585808T3 (da) | Modificerede serpiner til behandlingen af bradykinin formidlet sygdom | |
| DK3687825T3 (da) | Optisk sikkerhedselement | |
| DK3723791T3 (da) | Rekombinante igg-fc-multimere til behandling af neuromyelitis optica | |
| DK3373931T3 (da) | Heterocykliske forbindelser til behandling af sygdom | |
| DK3302573T3 (da) | Sammensætning til behandlingen af hjernelæsioner | |
| DK3229827T3 (da) | Modificerede peptider og anvendelse deraf til behandling af kroniske inflammatoriske sygdomme | |
| DK3209295T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3743064T3 (da) | Behandling af proteinuri | |
| DK3630164T3 (da) | Dulaglutid til behandling af kronisk nyresygdom |